HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Jung Selected Research

Therapeutics

1/2022Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers.
1/2022Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
1/2022Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
11/2021p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy.
11/2021Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial).
10/2021Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
4/2021Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting.
1/2021Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.
1/2021Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation.
1/2020Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Jung Research Topics

Disease

64Neoplasms (Cancer)
07/2022 - 04/2003
63Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 06/2002
18Neoplasm Metastasis (Metastasis)
01/2022 - 01/2004
14Colonic Neoplasms (Colon Cancer)
01/2019 - 03/2007
8Microsatellite Instability
07/2022 - 06/2002
8Infections
01/2022 - 08/2002
8Carcinogenesis
10/2013 - 10/2004
6Inflammation (Inflammations)
06/2022 - 05/2003
6Carcinoma (Carcinomatosis)
08/2012 - 02/2004
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 01/2011
5Cystic Fibrosis (Mucoviscidosis)
10/2021 - 03/2013
4Disease Progression
01/2022 - 05/2009
4Lung Neoplasms (Lung Cancer)
11/2021 - 03/2011
4Adenocarcinoma
11/2018 - 09/2006
4Pancreatic Neoplasms (Pancreatic Cancer)
08/2014 - 08/2012
4Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
08/2010 - 07/2002
3Asthma (Bronchial Asthma)
12/2017 - 07/2011
3Metaplasia
11/2014 - 08/2004
3Adenoma (Adenomas)
09/2012 - 02/2004
2COVID-19
11/2022 - 01/2022
2Hypersensitivity (Allergy)
11/2022 - 03/2013
2Pseudomonas Infections
10/2021 - 03/2013
2Chronic Obstructive Pulmonary Disease (COPD)
02/2016 - 01/2016
2Weight Loss (Weight Reduction)
04/2011 - 12/2010
2Virus Diseases (Viral Diseases)
11/2006 - 05/2006
2Chylothorax
05/2006 - 11/2005
2Stroke (Strokes)
05/2005 - 05/2003
1Immediate Hypersensitivity
11/2022
1Ciliary Motility Disorders (Primary Ciliary Dyskinesia)
01/2022
1Lung Diseases (Lung Disease)
10/2021
1Endometrial Neoplasms (Endometrial Cancer)
11/2018

Drug/Important Bio-Agent (IBA)

16beta CateninIBA
08/2010 - 06/2002
15Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2009
14Cetuximab (Erbitux)FDA Link
01/2022 - 03/2011
12Bevacizumab (Avastin)FDA Link
01/2022 - 09/2014
12ErbB Receptors (EGF Receptor)IBA
01/2021 - 03/2009
11DNA (Deoxyribonucleic Acid)IBA
06/2022 - 06/2002
9Irinotecan (Camptosar)FDA LinkGeneric
11/2021 - 03/2011
9Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2004
9CateninsIBA
09/2015 - 11/2010
7AntibodiesIBA
01/2021 - 05/2003
5Messenger RNA (mRNA)IBA
11/2022 - 08/2010
5Formaldehyde (Formol)FDA Link
12/2021 - 05/2012
5RNA (Ribonucleic Acid)IBA
01/2021 - 05/2006
5Codon (Codons)IBA
01/2017 - 01/2009
4LigandsIBA
12/2020 - 08/2008
4ParaffinIBA
01/2020 - 05/2012
4Monoclonal AntibodiesIBA
04/2016 - 08/2002
4Antiviral Agents (Antivirals)IBA
02/2016 - 05/2006
4Oncogene Proteins (Oncogene Protein)IBA
01/2007 - 07/2002
3Oxygen (Dioxygen)IBA
01/2022 - 08/2012
3Fluorouracil (Carac)FDA LinkGeneric
11/2021 - 09/2014
3Leucovorin (Folinic Acid)FDA Link
11/2021 - 09/2014
3Cell-Free Nucleic AcidsIBA
01/2020 - 03/2011
3Transcription Factors (Transcription Factor)IBA
01/2018 - 12/2005
3Immunoglobulin E (IgE)IBA
12/2017 - 07/2011
3GemcitabineFDA Link
01/2017 - 08/2012
3Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2014 - 04/2013
3Capecitabine (Xeloda)FDA Link
05/2013 - 03/2011
3Calcibiotic Root Canal SealerIBA
09/2012 - 09/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2012 - 08/2008
3Cyclin-Dependent Kinase Inhibitor p16IBA
07/2011 - 01/2009
3Biological ProductsIBA
12/2009 - 09/2006
2NucleotidesIBA
07/2022 - 01/2020
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 12/2017
2Circulating Tumor DNAIBA
01/2022 - 10/2017
2Azithromycin (Zithromax)FDA LinkGeneric
10/2021 - 02/2015
2Phosphotransferases (Kinase)IBA
01/2020 - 01/2020
2tyrosine receptor (receptor, tyrosine)IBA
01/2020 - 01/2020
2Indicators and Reagents (Reagents)IBA
01/2018 - 07/2011
2Therapeutic UsesIBA
01/2018 - 01/2012
2Differentiation AntigensIBA
11/2017 - 04/2014
2Insulin (Novolin)FDA Link
01/2017 - 12/2010
2ChemokinesIBA
03/2013 - 09/2012
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2013 - 03/2011
2VimentinIBA
11/2012 - 06/2011
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2012 - 11/2010
2LipidsIBA
04/2011 - 12/2010
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2008 - 05/2006
2Octreotide (Sandostatin)FDA LinkGeneric
05/2006 - 11/2005
2Plasminogen Activators (Plasminogen Activator)IBA
05/2005 - 02/2004
1COVID-19 VaccinesIBA
11/2022
1VaccinesIBA
11/2022
1mRNA VaccinesIBA
11/2022
1Aurora Kinase AIBA
01/2022
1Crk-Associated Substrate ProteinIBA
11/2021
1Immune Checkpoint InhibitorsIBA
10/2021
1B7-H1 AntigenIBA
10/2021
1AmphiregulinIBA
12/2020
1MagnesiumIBA
01/2020
1Hormones (Hormone)IBA
12/2019
1Cellular Retinol-Binding ProteinsIBA
01/2019

Therapy/Procedure

30Therapeutics
01/2022 - 03/2009
5Drug Therapy (Chemotherapy)
01/2019 - 04/2003
2Critical Care (Surgical Intensive Care)
11/2020 - 07/2009
2Combination Drug Therapy (Combination Chemotherapy)
01/2020 - 01/2019
2Precision Medicine
01/2020 - 04/2016
1Investigational Therapies (Experimental Therapy)
07/2022
1Chemoradiotherapy
10/2021
1Lung Transplantation
10/2021